Locally Advanced Basal Cell Carcinoma
Also known as: Locally advanced basal cell carcinoma (BCC)
Drug | Drug Name | Drug Description |
---|---|---|
DB14707 | Cemiplimab | A programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. |
DB08828 | Vismodegib | A hedgehog pathway inhibitor used to treat patients with locally advanced or metastatic basal cell carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14707 | Cemiplimab | 2 | Recruiting | 1 |
DB09143 | Sonidegib | 2 | Recruiting | 1 |
DB08828 | Vismodegib | 2 | Completed | 1 |
DB08828 | Vismodegib | 4 | Completed | 1 |
DB09143 | Sonidegib | Not Available | Recruiting | 1 |
DB08828 | Vismodegib | Not Available | Recruiting | 1 |